Oklo Trades at $43. Wall Street's Average Target Is $75. Here's What I Think It's Actually Worth.

Oklo (NYSE: OKLO), a developer of microreactors for nuclear power plants, has been a divisive stock since its market debut. After going public through a merger with a special purpose acquisition company (SPAC) on May 10, 2024, Oklo started trading at $15.50 per share.

It soared to a record high of $174.14 on Oct. 14, 2025, but it now trades at about $43. Wall Street's average price target for the stock is about $75. Let's see why Oklo's stock went through so many wild swings -- and where I think it will actually end up by the end of 2026.

Image source: Getty Images.

Why is Oklo such a volatile stock?

Oklo's Aurora microreactor, which is much smaller than conventional nuclear reactors, only generates 1.5 MWe per unit. However, its modular design allows it to be deployed alongside additional reactors to generate up to 75 MWe per "Powerhouse" power plant. That's tiny compared to a conventional nuclear power plant, which typically generates at least 1,000 MWe, but Aurora's Powerhouse plants can be deployed on less land in remote, off-grid areas.

The Aurora also uses metallic uranium fuel pellets, which are denser, have higher thermal resistance, and are cheaper to produce than the uranium dioxide fuel pellets that power conventional reactors. By recycling its pellets in a closed loop, the Aurora can last for a decade without refueling. Conventional reactors are still refueled in stages every two years.

Oklo's Aurora microreactors could represent a major leap forward for the nuclear energy market and meet the soaring energy needs of the cloud and AI markets. However, Oklo hasn't deployed a single commercial reactor or generated any meaningful revenue yet. That makes it hard to justify its $8.1 billion valuation -- so its stock became a yo-yo for short-term traders.

How much will Oklo be worth by the end of 2026?

Groves One, Oklo's first pilot isotope-production reactor, achieved criticality (a controlled, self-sustaining nuclear chain reaction) for the first time in early August. It deployed that reactor in just 229 days, marking the fastest construction of a U.S. non-military reactor in recent history.

Oklo plans to deploy its first commercial reactors in Idaho in 2027. Assuming that happens, analysts expect its revenue to rise from $7.9 million in 2027 to $53.3 million in 2028. But at its current market, it still looks overvalued at 153 times its 2028 sales.

In a warmer market, Oklo might attract a higher valuation as more investors rotate toward higher-growth and speculative stocks. But in this choppy market -- which faces inflation, potential rate hikes, geopolitical conflicts, and other headwinds -- I don't expect Oklo to attract too many risk-seeking investors. Without any clearer visibility into its revenue growth potential in 2027, 2028, and beyond, I expect Oklo's stock to trade sideways or dip lower through the end of the year.

Leo Sun has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.